Showing results (51-60 of 102) with videos related to
Sort By:
Pageof 11
Database : the Journal of Biological Databases and Curation|December 9, 2025
From library to landscape: integrative annotation workflows for compound libraries in drug repurposingJeanette Reinshagen, Brinton Seashore-Ludlow, Yojana Gadiya, et al.Scientific Data|February 27, 2021
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collectionBernhard Ellinger, Denisa Bojkova, Andrea Zaliani, et al.European Journal of Medicinal Chemistry|November 4, 2022
Easy access to α-ketoamides as SARS-CoV-2 and MERS Mpro inhibitors via the PADAM oxidation routeSveva Pelliccia, Carmen Cerchia, Francesca Esposito, et al.Patterns (New York, N.Y.)|April 20, 2026
Experimental and machine learning-based exploration of repurposed drugs reveals chemical features underlying phospholipidosisMaria Kuzikov, Adelinn Kalman, Reagon Karki, et al.Journal of Biological Methods|August 28, 2019
Development and implementation of a cell-based assay to discover agonists of the nuclear receptor REV-ERBαYuliya Hering, Alexandre Berthier, Helene Duez, et al.ACS Pharmacology & Translational Science|August 14, 2025
Optimization and Evaluation of Complementary Degrader Discovery Assays for Application in ScreeningJohanna Huchting, Arjen Weller, Moyra Schweizer, et al.Virus Research|March 15, 2024
Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complexMaria Kuzikov, Jeanette Reinshagen, Krzysztof Wycisk, et al.Assay and Drug Development Technologies|April 17, 2014
A phenotypic screening approach to identify anticancer compounds derived from marine fungiBernhard Ellinger, Johanna Silber, Anjali Prashar, et al.Journal of Biomolecular Screening|September 29, 2004
Development and automation of a 384-well cell fusion assay to identify inhibitors of CCR5/CD4-mediated HIV virus entryJoe Bradley, Jasween Gill, Francois Bertelli, et al.ACS Pharmacology & Translational Science|April 18, 2022
Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme ActivitiesAngela Corona, Krzysztof Wycisk, Carmine Talarico, et al.Pageof 11